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Aim of the Study: Silent acute myocardial infarction occurs commonly in diabetic patients. Currently, it is not fully understood 
whether altered perception of ischemia also predisposes atypical presentations, and therefore leads to under-diagnosing the 
acute myocardial infarction (AMI) in diabetic patients. In this study, we tried to determine whether chest pain in AMI occurred 
less frequently in diabetic patients. Methods: In this retrospective study, we included patients admitted from April 2014 to 
November 2019. Data were collected using eHitna and BIS as the nation-wide programs for patient tracking and registry in 
Croatia. All patients included in the study had initially called Department of Emergency Medicine of Brod-Posavina County, 
which then resulted in an intervention. Patients were then transferred to Dr Josip Benčević General Hospital, where they 
were hospitalized. All patients had discharge letters with the diagnosis specifi ed by ICD-10 classifi cation as I21 spectrum 
(I21.0, I21.1, I21.2, I21.3, I21.4, I21.9), i.e. AMI. Results: In this study, we included 180 patients having suffered AMI who 
were hospitalized and treated. There were 35 (19%) diabetic patients (DP) and 145 (81%) non-diabetic patients (non-DP). 
Chest pain was absent in nine (26%) DP and 13 (9%) non-DP (p=0.007). There was no difference in sex distribution within 
the two groups, with 60% and 68% male patients in DP and non-DP, respectively (p=0.395). The mean patient age was 
signifi cantly different between the two groups, i.e. 69 years in DP and 64 years in non-DP (p=0.034). Discussion: AMI in 
diabetic patients could have altered clinical presentation, which has often been researched therefore. Some researchers 
have reported that atypical or silent presentations are more frequent in DP with AMI, whereas others found no differences 
when compared to non-DP. In our study, absence of chest pain as a characteristic of silent AMI was experienced by 17% 
more DP as compared to non-DP, suggesting that DM infl uences clinical presentation of AMI. It is important to emphasize the 
importance of such fi ndings in emergency medicine where patients often describe their various symptoms. The mean age 
of DP having suffered AMI was signifi cantly higher (even up to 5 years) in comparison to non-DP. Despite the fact that DM is 
a risk factor for developing AMI, this fi nding could be explained by the fact that DM is more common in elderly population. 
Conclusion: Chest pain occurs signifi cantly less frequently in DP that develop AMI than in non-DP. Therefore, DP have a 
higher probability of developing silent AMI.
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INTRODUCTION
Cardiovascular diseases are the leading cause of mor-
bidity and mortality worldwide. Th is is true in all areas 
of the world except for Africa (1). Cardiovascular com-
plications are also the leading cause of morbidity and 
mortality among patients with diabetes mellitus (DM). 
Th e risk of cardiovascular diseases is two to four times 
higher among people with DM than in other popula-
tions (2).
Acute myocardial infarction (AMI), also known as 
heart attack, occurs when blood fl ow decreases or stops 
to a part of the heart, referred to as ischemia, thus caus-
ing damage to the heart muscle. Th e most common 
symptom is chest pain or discomfort, which may ra-
diate to the shoulder, arm, back, neck or jaw (3). Chest 
pain occurs due to the ‘crosstalk’ between somatic and 
visceral aff erent neural pathways (4).
In patients with diabetes, however, several studies have 
reported that ischemia may be painless or experienced 
atypically (5-7). Several explanations are possible for 
this atypical presentation. Cardiac autonomic neu-
ropathy almost certainly plays an important role, po-
tentially involving dysfunction at varying levels, from 
pain receptors, aff erent neurons or gating mechanisms 
to the supratentorial translation of ischemia into pain 
(8). Such silent AMI, defi ned as the objective evidence 
for acute myocardial ischemia in the absence of symp-
toms, particularly chest pain, has important clinical 
implications for the patient with coronary artery dis-
ease and diabetes, especially in emergency medicine. 
THE AIM OF THE STUDY
Silent AMI occurs commonly in diabetic patients. It 
is currently not fully understood whether altered per-
ception of ischemia also predisposes atypical presenta-
tions and therefore leads to under diagnosing AMI in 
diabetic patients. In this study, we tried to determine 
whether chest pain in AMI occurred less frequently in 
diabetic patients. Also, we tried to assess the impact of 
the potential factors such as age and sex. Finally, we 
describe clinical presentation of the patients having 
suff ered from silent AMI.
METHODS
In this retrospective study, we included patients in pe-
riod from April 2014 to November 2019. Data were 
collected using eHitna and BIS as the nation-wide pro-
grams for patient tracking and registry in Croatia.
All patients included in the study had initially called 
Department of Emergency Medicine of Brod-Posav-
ina County, which then resulted in an intervention. 
Patients were then transferred to Dr Josip Benčević 
General Hospital where they were hospitalized. Th ese 
patients underwent either coronary catheterization, 
were treated conservatively, or developed cardiac shock 
and died. All patients had discharge letters with the di-
agnosis specifi ed by ICD-10 classifi cation as I21 spec-
trum (I21.0, I21.1, I21.2, I21.3, I21.4, I21.9), i.e. AMI. 
Chest pain was assessed by physicians ranging from 0 
(no pain), 1 (mild pain) to 2 (strong pain). Diabetes 
was recorded in patients on insulin or oral hypoglyce-
mic drugs and included both type 1 and type 2 dia-
betes. Time of arrival was defi ned as the time it took 
for the emergency ambulance to arrive to the place of 
intervention, for town area and rural area, under ten 
and twenty minutes, respectively. Hemodynamic insta-
bility referred to systolic blood pressure ≤90 mm Hg. 
Th erapies applied and included in analysis were ace-
tylsalicylic acid, oxygen, nitroglycerin and morphine.
Data were analyzed in Microsoft  Offi  ce Excel. Th e χ2-
test was used to determine the relationship between 
chest pain in diabetics and non-diabetics. It was also 
used to assess diff erence in sex ratio between two 
groups. T-independent test was used to assess the sig-
nifi cance of between-group diff erence in mean age. Th e 
value of p<0.05 was considered statistically signifi cant.
RESULTS
In this study, we included 180 patients having suff ered 
AMI and hospitalized for treatment. Th ere were 35 
(19%) diabetic patients (DP) and 145 (81%) non-dia-
betic patients (non-DP). Chest pain was absent in nine 
(26%) DP and 13 (9%) non-DP (p=0.007) (Figure 1).
Th ere was no diff erence in sex distribution within the 
two groups, with 60% and 68% male patients in DP and 
non-DP, respectively (p=0.395). Th e mean patient age 
was signifi cantly diff erent between the two groups, i.e. 
69 years in DP and 64 years in non-DP (p=0.034). Fig-
ure 2 illustrates age distribution among DP and non-
DP. Th e recommended time of arrival was achieved in 
144 (86%) interventions.
We analyzed clinical presentation of patients having 
suff ered AMI in the absence of chest pain. Th ere were 
22 (12%) patients, both DP and non-DP, who felt no 
pain. We analyzed hemodynamic instability and al-
tered level of consciousness. Table 1 shows their char-
acteristics. Percentages of the four most frequently ad-
ministered therapies in DP and non-DP are shown in 
Table 2.
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Fig. 1. Chest pain frequency.
Frequency of chest pain experienced by diabetic pa-
tients (N=35) and non-diabetic patients (N=145). 
Chest pain was assessed as no pain, mild pain and seve-
re pain. Th ere was a signifi cantly higher prevalence of 
patients with absence of pain in diabetic patients than 
in non-diabetic patients (26% and 9%, respectively; 
p=0.007). fi gure 2
Fig. 2. Patient distribution according to age (years).
Age distribution of diabetic patients (N=35) and 
non-diabetic patients (N=145): mean age was was 69 
and 64 years in diabetic patients and non-diabetic pa-
tients, respectively; p=0.034).




Mean age (years) 62




Altered level of consciousness
and hemodynamically unstable
4 (18%)
Characteristics of patients who had no chest pain and 
suff ered acute myocardial infarction: among other 
symptoms recorded in these patients were nausea, vo-
miting, syncope, dizziness and dyspnea.
*Hemodynamically unstable refers to patients with 
systolic blood pressure ≤90 mm Hg.





Therapy administered n (%) n (%)
Acetylsalicylic acid 31 (89) 131 (90)
Oxygen 30 (86) 115 (79)
Nitroglycerin 19 (54) 84 (58)
Morphine 4 (11) 19 (13)
As expected, morphine was more frequently used in non-diabetic patients.
DISCUSSION 
Acute myocardial infarction MI in diabetic patients 
may have altered clinical presentation and therefore 
is has been widely researched. Some researchers have 
reported that atypical or silent presentations are more 
frequent in diabetic patients with AMI (9-17), whereas 
others found no diff erences when compared to non-di-
abetic patients (18-23). In our study, absence of chest 
pain as a characteristic of silent AMI was recorded in 
17% more DP as compared to non-DP, suggesting that 
DM infl uences clinical presentation of AMI. It is im-
portant to emphasize the importance of such fi ndings 
in emergency medicine where patients oft en describe 
their various symptoms. 
In 22 patients who suff ered AMI in the absence of 
characteristic chest pain, 18% had altered levels of con-
sciousness, so they may not have correctly estimated 
the severity of chest pain. Others, on the other hand, 
presented atypical symptoms such as nausea, vomiting, 
syncope, dizziness or dyspnea. 
Diabetes mellitus and its chronic complications pose a 
major health problem all over the world. It is estimat-
ed that currently 366 million people suff er from DM 
worldwide and that by the year 2030 the number of di-
abetics will increase to 552 million. Th e prevalence of 
DM is rising in all countries, and 80% percent of the 
world population suff ering from diabetes live in de-
veloping countries or newly industrialized countries 
(24). In Croatia, the number of diabetics in 2010 was 
approximately 316,000, of which over 190,000 patients 
had been diagnosed with the disease, while nearly 
123,000 remained undiagnosed (25). Th e mean age of 
diabetic patients who suff ered AMI was signifi cantly 
higher, even up to 5 years, than in those without DM. 
Despite the fact that DM is a risk factor for developing 
AMI, this fi nding could be explained by the fact that 
DM is more common in elderly population. 
Th e factors of the emergency medicine effi  ciency are 
time to response and availability. According to quali-
ty indicators that are systematically monitored by the 
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Croatian Institute of Emergency Medicine, in 80% of 
cases emergency medicine teams arrive at the place of 
intervention no later than 10 minutes from the call in 
urban areas and 20 minutes from the call in rural areas 
(26). Th e result regarding the time of arrival to the in-
tervention was by 6% higher in this study.
Th e administration of morphine is widely accepted 
as treatment for chest pain in the setting of an AMI 
(27). In a large retrospective cohort study, in-hospital 
complications and 1-year mortality were unaff ected by 
pre-hospital morphine use in patients with ST elevation 
myocardial infarction (STEMI), implying its safety in 
this patient population (28). However, there have been 
several studies questioning the safety of morphine use 
in patients with AMI, citing delayed and decreased ef-
fi cacy of antiplatelet agents (28,29). In this study, mor-
phine was used more frequently in non-DP patients. 
Out of all 158 patients having experienced chest pain, 
morphine as analgesic therapy was administered in 7% 
of patients with mild pain and 25% of patients with 
severe pain. Table 2 shows that oxygen therapy was 
used in high frequencies. Since the patients had been 
recorded from 2014, this can be explained by the then 
nonexistence of the latest guidelines for oxygen therapy 
in AMI, which suggest applying it only if blood satura-
tion is lower than 90%. 
CONCLUSION
Chest pain occurs signifi cantly less frequently in dia-
betic patients who develop AMI than in non-diabet-
ic patients. Th erefore, diabetic patients have a higher 
probability of developing silent AMI. Th ere was no dif-
ference in sex distribution within the two groups, while 
the mean age diff ered signifi cantly between the two 
groups, i.e. diabetic patients were older on average. Th e 
rate of recommended time of arrival at the intervention 
was higher than stated in the offi  cial guidelines.
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SAŽETAK
NIJEMI AKUTNI INFARKT MIOKARDA KOD BOLESNIKA SA ŠEĆERNOM BOLESTI U IZVANBOLNIČKOJ HITNOJ MEDICINI
M. OMERBAŠIĆ1, J. GLAVIĆ1, A. MIŠKOVIĆ1, B. BARDAK1, K. CVITKUŠIĆ LUKENDA2 i B. MIŠKIĆ2,3
1Zavod za hitnu medicinu Brodsko-posavske županije, Slavonski Brod, 2Opća bolnica ¨Dr. Josip Benčević¨, Slavonski Brod, 
3Sveučilište J. J. Strossmayera u Osijeku, Medicinski fakultet Osijek, Fakultet za dentalnu medicinu i zdravstvo, Osijek, 
Hrvatska
Cilj: Nijemi akutni infarkt miokarda (AIM) se pojavljuje češće u bolesnika s dijabetesom. Predisponira li izmijenjena percepcija 
ishemije atipičnu prezentaciju te se zbog toga nedovoljno dijagnosticira AIM u bolesnika s dijabetesom, nije još dovoljno 
istraženo. U ovoj studiji pokušali smo utvrditi pojavljuje li se bol u prsištu kod AIM rjeđe kod bolesnika s dijabetesom. Me-
tode: U ovu retrospektivnu studiju uključili smo bolesnike primljene od travnja 2014. do studenoga 2019. godine. Koristili 
smo bazu podataka programa “e-hitna” i “BIS” te sakupljali i analizirali podatke o bolesnicima koji su zatražili intervenciju 
izvanbolničke hitne medicinske službe u našoj županiji, bili prevezeni u Opću bolnicu “Dr. Josip Benčević”, hospitalizirani te 
im je kao otpusna dijagnoza postavljena prema klasifi kaciji MKB-10 bila u spektru dijagnoze I21 (I21.0, I21.1, I21.2, I21.3, 
I21.4, I21.9), tj. AIM. Dijabetes je zabilježen kod bolesnika koji su bili na inzulinu ili oralnim hipoglikemicima, uključujući 
dijabetes tip 1 i tip 2. Rezultati: U studiju smo uključili 180 bolesnika koji su doživjeli AIM. Od tog broja ih je 35 (19,4 %) 
imalo dijabetes (DP), a 145 (80,6 %) nije imalo dijabetes (ne-DP). Bol u prsištu nije bila prisutna u devet (26 %) DP i 13 (9 
%) ne-DP (p=0,007). Nije bilo značajne razlike u distribuciji prema spolu ni u jednoj skupini bolesnika (p=0,35). Muškaraca 
je bilo 60 % u DP i 68 % u ne-DP. Prosječna dob značajno se razlikovala u dvjema skupinama. U DP je prosječna dob bila 69 
godina, a u ne-DP 64 godine (p=0,034). Rasprava: Akutni infarkt miokarda u bolesnika s dijabetesom može se prezentirati 
izmijenjenom kliničkom slikom i zbog toga se često istraživao. Neki istraživači su pokazali da je atipična ili nijema prezentaci-
ja infarkta češća u bolesnika s dijabetesom, dok drugi nisu pronašli razlike u usporedbi s nedijabetičarima. U ovoj studiji smo 
primijetili da je izostanak boli u prsištu kao karakteristika nijemog AMI učestaliji u dijabetičara s AIM. To dovodi do zaključka 
da dijabetes utječe na kliničku sliku AIM. Treba istaknuti važnost takvog rezultata u izvanbolničkoj hitnoj medicini gdje se 
bolesnici često prezentiraju raznim simptomima. Srednja vrijednost dobi dijabetičara koji su doživjeli AIM bila je značajno 
veća nego u nedijabetičara. Unatoč činjenici da je dijabetes rizični čimbenik za razvoj AIM, ovaj rezultat možemo tumačiti 
činjenicom da je dijabetes zastupljeniji u starijoj populaciji. Zaključak: Bol u prsištu se javlja rjeđe u bolesnika s dijabetesom 
koji imaju AIM nego u onih koji nemaju dijabetes. Zbog toga dijabetičari imaju veće izglede da razviju nijemi AIM..
KLJUČNE RIJEČI: tihi akutni infarkt miokarda, šećerna bolest, bol u prsištu, bolesnici sa šećernom bolešću
